iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Shreehas Tambe assumes charge as MD -; CEO of Biocon Biologics

6 Dec 2022 , 10:44 AM

Biocon

Shreehas Tambe, Deputy CEO of Biocon Biologics, has been appointed as the Managing Director and CEO, effective December 5, 2022, of Biocon Biologics Limited (BBL), a subsidiary of Biocon Limited.

Tambe will guide BBL toward its goal of becoming a global biosimilar leader.

Tambe succeeds Arun Chandavarkar, who will continue to serve on the Board of Biocon Biologics as a non-executive, non-independent director.

Shreehas Tambe, Deputy CEO of Biocon Biologics since March 2021, has played an important and very effective role in assisting Arun Chandavarkar in steering the company toward sustainable growth and laying a strong foundation for the future.

Shreehas Tambe has been associated with Biocon since 1997, serving in a variety of leadership and operational roles. He has helped build and shape Biocon’s biosimilars business over the last 25 years, as well as spearheading the Group’s strategic capital investments, including its first overseas facility in Malaysia.

Shreehas has also been instrumental in obtaining regulatory approvals and successfully launching several of the company’s biosimilar assets in global markets such as the United States and the European Union.


At around 10.47 AM, Biocon was trading at Rs276.55 down by 0.9% from its previous closing of Rs279.05 on the BSE. The scrip opened at Rs279.95 and touched intraday high and low of Rs280.30 and Rs276.20 respectively.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Biocon Biologics
  • Biocon news
  • Biocon results
  • Biocon Share
  • Biocon Stock
  • Biocon Updates
  • BioconSharePrice
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.